"The recently reported positive outcomes from the two Phase 2 HIV-1 trials, BIT225-010 and BIT225-011, added to the previous positive data of BIT225. The drug has demonstrated broad spectrum antiviral activity in preclinical and clinical studies."
Am I missing something here. They start a paragraph like this and then can only manage two and a half lines with no information of the positives. Can't help feeling BIT is being set to fail and all their ip and compounds being sold off. If MM turns up in another company that has acquired BIT assets in any capacity I will definitely want her head on a chopping block.
BIT Price at posting:
2.2¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)